What is the Valiant Laboratories Ltd share price today?

The share price of NSE:VALIANTLAB-BE on 07 Sep 2026 (as of 11:00:30 IST) is ₹108.00.

What is the NSE:VALIANTLAB-BE 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:VALIANTLAB-BE 52 week high low range shows a high of ₹110.90 and a low of ₹49.51.

What is the Valiant Laboratories Ltd market cap?

As on 07 Sep 2026, Valiant Laboratories Ltd market cap is ₹582.61 Cr.

What is the shareholding pattern of Valiant Laboratories Ltd Stock?

The shareholding pattern of Valiant Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 74.94% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 25.06% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Valiant Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Valiant Laboratories Ltd is 36.40, and the Price-to-Book (PB) ratio is 1.42, as on 07 Sep 2026.

Valiant Laboratories Share Price

123.15+1.91 (+1.58%)

+39.88% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Valiant Laboratories Share Price

123.15+1.91 (+1.58%)

+39.88% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year-27%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year-789%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year38%

Return on Equity

10 years9%

5 years9%

3 years9%

Last year-1%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	-27%
-	-	-	-789%
-	-	-	38%
9%	9%	9%	-1%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

VALIANTLAB-BE

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,849.9	₹447476 Cr	37	12.07	62.82	₹11479 Cr
9,602	₹254764 Cr	87.1	34.04	128.41	₹2568 Cr
4,928.5	₹189423 Cr	86.85	16.72	97.06	₹2163 Cr
1,180.3	₹116658 Cr	25.85	9.42	62.53	₹5040 Cr
1,399	₹111484 Cr	33.08	9.77	57.87	₹3879 Cr
2,026.2	₹109943 Cr	100.55	6.8	29.25	₹889 Cr
2,500	₹101712 Cr	49.79	13.75	71.08	₹1913 Cr
1,200.4	₹101005 Cr	31.35	5.32	63.99	₹4196 Cr
1,716	₹99253 Cr	26.73	17.95	96.84	₹3505 Cr
2,100.7	₹96031 Cr	17.37	30.95	154.35	₹5333 Cr
123.15	₹668 Cr	41.72	3.89	4.49	-₹3 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Long Term Loans & Advances

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2025	Mar 2024	Mar 2023
—	—	—
₹43 Cr	₹43 Cr	₹33 Cr
₹191 Cr	₹193 Cr	₹68 Cr
₹191 Cr	₹193 Cr	₹68 Cr
₹234 Cr	₹237 Cr	₹100 Cr
₹45 Cr	₹15 Cr	₹0
₹59 Cr	₹59 Cr	₹59 Cr
₹1 Cr	₹62 L	₹67 L
₹1 Cr	₹1 Cr	₹2 Cr
₹13 L	₹8 L	₹8 L
₹107 Cr	₹77 Cr	₹62 Cr
—	—	—
₹41 Cr	₹26 Cr	₹47 Cr
₹2 Cr	₹2 Cr	₹3 Cr
₹17 Cr	₹1 Cr	₹0
₹20 L	₹12 L	₹12 L
₹60 Cr	₹29 Cr	₹51 Cr
₹401 Cr	₹343 Cr	₹213 Cr
₹62 Cr	₹3 L	₹3 L
₹121 Cr	₹76 Cr	₹59 Cr
—	—	—
₹71 Cr	₹70 Cr	₹66 Cr
₹22 Cr	₹20 Cr	₹18 Cr
₹48 Cr	₹50 Cr	₹48 Cr
₹156 Cr	₹43 Cr	₹68 L
₹4 Cr	₹24 Cr	₹14 Cr
₹208 Cr	₹117 Cr	₹62 Cr
—	—	—
₹0	₹38 Cr	₹34 Cr
₹4 Cr	₹10 Cr	₹13 Cr
₹72 Cr	₹46 Cr	₹89 Cr
₹76 Cr	₹106 Cr	₹1 Cr
₹81 L	₹2 Cr	₹1 Cr
₹40 Cr	₹24 Cr	₹12 Cr
₹193 Cr	₹226 Cr	₹151 Cr
₹133 Cr	₹196 Cr	₹100 Cr
₹401 Cr	₹343 Cr	₹213 Cr
₹54	₹55	₹31
₹50	₹51	₹31

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2025	Mar 2024	Mar 2023
-₹2 Cr	-₹77 L	₹38 Cr
₹4 Cr	₹2 Cr	₹2 Cr
-₹4 Cr	-₹37 L	₹25 Cr
-₹1 Cr	₹90 L	₹65 Cr
₹1 Cr	₹2 Cr	₹56 Cr
-₹53 Cr	-₹144 Cr	-₹55 Cr
₹45 Cr	₹152 Cr	-₹93 L
-₹7 Cr	₹10 Cr	-₹5 L
₹12 Cr	₹1 Cr	₹1 Cr
₹5 Cr	₹12 Cr	₹1 Cr

Fundamental Ratios

Consolidated

Standalone

Valiant Laboratories Share Price

123.15+1.91 (+1.58%)

+39.88% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Valiant Laboratories Share Price

123.15+1.91 (+1.58%)

+39.88% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 6

Bearish signals: 0 out of 9 oscillators

RSI

65.12Buy

STOCH %K

67.67Neutral

MACD Level(12,26)

9.99Buy

Ultimate Oscillator

55.47Buy

Aroon Oscillator

72.00Buy

BOP

0.22Buy

CCI

55.68Neutral

Williams %R

-32.33Neutral

Momentum

22.22Buy

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 8

Bearish signals: 1 out of 9 moving averages

EMA 9

121.76Buy

SMA 9

123.50Sell

EMA 21

113.41Buy

SMA 21

113.44Buy

EMA 50

97.61Buy

SMA 50

89.52Buy

EMA 200

80.04Buy

SMA 200

71.76Buy

WMA 20

119.24Buy

Pivot

Classic

Resistance 5

158.53

Resistance 4

149.77

Resistance 3

141.01

Resistance 2

132.25

Resistance 1

126.75

Pivot

123.49

Support 1

117.99

Support 2

114.73

Support 3

105.97

Support 4

97.21

Support 5

88.45

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

117.30

91.53

58.08

51.00

49.51

High

125.99

132.25

199.64

Returns

+1.91

-0.11

+17.67

+55.15

+69.58

+53.15

+35.11

—

-27.45

Beta

—

Std. deviation %

—

Sign in to view

Open a free Demat account in minutes to start investing and screening .

Valiant Laboratories Share Price

123.15+1.91 (+1.58%)

+39.88% past 1 Year

Shareholding summary

Promoters

74.94%

FII

0%

DII

0%

MF

0%

Others

25.06%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
74.94%	74.94%	74.94%	74.94%	74.94%	74.94%
0.00%	0.20%	0.01%	0.02%	0.63%	0.64%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
25.06%	24.86%	25.05%	25.04%	24.43%	24.42%

Bulk & block deals

Name

Metasoni Alloys Pvt Ltd

Trade Corner

Necta Bloom Vcc - Necta Bloom One

Marwadi Chandarana Intermediaries Brokers Private Limited

Money Logix Securities Pvt Ltd

Jainam Broking Limited

Jaliyan Commodity

Jainam Broking Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
17 Dec 2025	Purchase	2.10 Cr	₹67.33	3.12 L	Bulk	0.574452	NSE
17 Dec 2025	Sell	5.19 L	₹66.98	7.74 K	Bulk	0.014255	NSE
13 Jun 2025	Sell	2.83 Cr	₹120.29	2.35 L	Bulk	0.433049	NSE
31 Jan 2025	Purchase	2.83 Cr	₹102.75	2.75 L	Bulk	0.506329	NSE
31 Jan 2025	Sell	2.83 Cr	₹102.75	2.75 L	Bulk	0.506329	NSE
24 Jan 2025	Purchase	5.82 Cr	₹105.78	5.50 L	Bulk	1.012658	NSE
24 Jan 2025	Sell	5.82 Cr	₹105.77	5.50 L	Bulk	1.012658	NSE
07 Jun 2024	Purchase	4.99 Cr	₹142.81	3.49 L	Bulk	0.642841	NSE
07 Jun 2024	Purchase	18.27 L	₹148.54	12.30 K	Bulk	0.022647	NSE
07 Jun 2024	Sell	4.92 Cr	₹142.80	3.44 L	Bulk	0.634071	NSE

Insider trading & SAST

Client name

Valiant Organics Ltd

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
10 Jun 2026	Promoter	Acquisition	34.26	—	0	—	1.86 Cr	01 Jan 1900	—	—	SAST	10(5)	—

Valiant Laboratories Share Price

123.15+1.91 (+1.58%)

+39.88% past 1 Year

Valiant Laboratories Limited is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. Bulk drugs/Active Pharmaceutical Ingredients (API) serve as raw materials for

Corporate Actions

Date

Type

Details

2025-07-18

Rights

1:4;75.0 (Rights ratio;Offer price)

Company details

Registered office

109, Udyog Kshetra, First Floor Mulund Goregaon Link Road Mulund (West) Mumbai Maharashtra PIN: 400080 Tel No: 022-49712001 / 49717220 / 49717221 Fax No: NULL Email: [email protected] Internet: www.valiantorganics.com

Registrars

C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/

Management

Mulesh M Savla, Non Executive Independent Director

Santosh S Vora, Managing Director

Paresh S Shah, Whole Time Director

Shantilal Shivji Vora, Non Executive Director

Sandeep Gupta, Non Executive Director

Sonal A Vira, Non Executive Independent Director

Akshay Gangurde, Company Secretary & Compliance Officer

Ashok Chheda, Non Executive Independent Director

Details

BSE 543998

NSE VALIANTLAB